Birdwatch Note
2023-08-13 00:47:01 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The FDA didn't change their stance on Ivermectin at all. Namely, they can not limit how Doctors prescribe a medication, but they have a right and duty to inform the public that it doesnt help for Covid, and it can be dangerous. They argued the same in 2022 and this week. https://www.courthousenews.com/ivermectin-proponents-ask-fifth-circuit-to-revive-lawsuit-against-fda
Written by 481D0AD0EBA3E2E3428E118D60051058C4D61094109D170A1D1221EB5C23E7C7
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1690499967675232256
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1690525329234735253
- noteId - 1690525329234735253
- participantId -
- noteAuthorParticipantId - 481D0AD0EBA3E2E3428E118D60051058C4D61094109D170A1D1221EB5C23E7C7 Participant Details
- createdAtMillis - 1691887621588
- tweetId - 1690499967675232256
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The FDA didn't change their stance on Ivermectin at all. Namely, they can not limit how Doctors prescribe a medication, but they have a right and duty to inform the public that it doesnt help for Covid, and it can be dangerous. They argued the same in 2022 and this week. https://www.courthousenews.com/ivermectin-proponents-ask-fifth-circuit-to-revive-lawsuit-against-fda
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-08-13 00:47:01 UTC (1691887621588) |
1969-12-31 23:59:59 UTC (-1) |
2023-08-14 02:09:58 UTC (1691978998272) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-08-13 17:53:54 -0500 | Rating Details | |
2023-08-13 16:43:49 -0500 | Rating Details | |
2023-08-13 16:26:44 -0500 | Rating Details | |
2023-08-13 16:22:40 -0500 | Rating Details | |
2023-08-13 16:18:48 -0500 | Rating Details | |
2023-08-13 16:17:26 -0500 | Rating Details | |
2023-08-13 16:17:21 -0500 | Rating Details | |
2023-08-13 16:09:46 -0500 | Rating Details | |
2023-08-13 16:03:25 -0500 | Rating Details | |
2023-08-13 16:01:50 -0500 | Rating Details | |
2023-08-13 15:44:45 -0500 | Rating Details | |
2023-08-13 15:33:45 -0500 | Rating Details | |
2023-08-13 15:32:21 -0500 | Rating Details | |
2023-08-13 14:52:31 -0500 | Rating Details | |
2023-08-13 14:28:37 -0500 | Rating Details | |
2023-08-13 13:40:13 -0500 | Rating Details | |
2023-08-13 13:11:36 -0500 | Rating Details | |
2023-08-13 13:02:39 -0500 | Rating Details | |
2023-08-13 13:00:56 -0500 | Rating Details | |
2023-08-13 12:48:18 -0500 | Rating Details | |
2023-08-13 12:41:01 -0500 | Rating Details | |
2023-08-13 12:39:37 -0500 | Rating Details | |
2023-08-13 12:23:27 -0500 | Rating Details | |
2023-08-13 12:22:40 -0500 | Rating Details | |
2023-08-13 11:20:52 -0500 | Rating Details | |
2023-08-13 10:36:06 -0500 | Rating Details | |
2023-08-13 10:24:52 -0500 | Rating Details | |
2023-08-13 10:05:21 -0500 | Rating Details | |
2023-08-13 09:59:26 -0500 | Rating Details | |
2023-08-13 09:33:45 -0500 | Rating Details | |
2023-08-13 09:28:10 -0500 | Rating Details | |
2023-08-13 09:22:32 -0500 | Rating Details | |
2023-08-13 09:07:53 -0500 | Rating Details | |
2023-08-13 09:03:42 -0500 | Rating Details | |
2023-08-13 08:49:51 -0500 | Rating Details | |
2023-08-13 08:41:16 -0500 | Rating Details | |
2023-08-13 08:37:22 -0500 | Rating Details | |
2023-08-13 08:28:14 -0500 | Rating Details | |
2023-08-13 08:08:02 -0500 | Rating Details | |
2023-08-13 07:58:34 -0500 | Rating Details | |
2023-08-13 07:50:08 -0500 | Rating Details | |
2023-08-13 07:44:51 -0500 | Rating Details | |
2023-08-13 06:54:57 -0500 | Rating Details | |
2023-08-13 06:52:48 -0500 | Rating Details | |
2023-08-13 06:51:37 -0500 | Rating Details | |
2023-08-13 06:49:20 -0500 | Rating Details | |
2023-08-13 06:45:52 -0500 | Rating Details | |
2023-08-13 06:17:54 -0500 | Rating Details | |
2023-08-13 06:16:51 -0500 | Rating Details | |
2023-08-13 05:45:37 -0500 | Rating Details | |
2023-08-13 05:44:11 -0500 | Rating Details | |
2023-08-13 05:30:03 -0500 | Rating Details | |
2023-08-13 04:06:18 -0500 | Rating Details | |
2023-08-13 03:23:10 -0500 | Rating Details | |
2023-08-13 03:17:33 -0500 | Rating Details | |
2023-08-13 02:31:56 -0500 | Rating Details | |
2023-08-13 02:17:06 -0500 | Rating Details | |
2023-08-13 01:57:13 -0500 | Rating Details | |
2023-08-13 01:38:10 -0500 | Rating Details | |
2023-08-13 01:31:10 -0500 | Rating Details | |
2023-08-13 01:27:01 -0500 | Rating Details | |
2023-08-13 01:05:17 -0500 | Rating Details | |
2023-08-13 00:34:23 -0500 | Rating Details | |
2023-08-13 00:28:54 -0500 | Rating Details | |
2023-08-13 00:23:48 -0500 | Rating Details | |
2023-08-13 00:15:45 -0500 | Rating Details | |
2023-08-13 00:04:02 -0500 | Rating Details | |
2023-08-12 23:35:51 -0500 | Rating Details | |
2023-08-12 23:15:06 -0500 | Rating Details | |
2023-08-12 23:11:22 -0500 | Rating Details | |
2023-08-12 22:58:31 -0500 | Rating Details | |
2023-08-12 22:48:37 -0500 | Rating Details | |
2023-08-12 22:42:39 -0500 | Rating Details | |
2023-08-12 22:24:43 -0500 | Rating Details | |
2023-08-12 22:13:27 -0500 | Rating Details | |
2023-08-12 21:52:26 -0500 | Rating Details | |
2023-08-12 21:45:36 -0500 | Rating Details | |
2023-08-12 21:42:05 -0500 | Rating Details | |
2023-08-12 21:25:11 -0500 | Rating Details | |
2023-08-12 21:20:24 -0500 | Rating Details | |
2023-08-12 21:07:15 -0500 | Rating Details | |
2023-08-12 21:06:32 -0500 | Rating Details | |
2023-08-12 21:05:38 -0500 | Rating Details | |
2023-08-12 20:53:32 -0500 | Rating Details | |
2023-08-12 20:52:26 -0500 | Rating Details | |
2023-08-12 20:51:23 -0500 | Rating Details | |
2023-08-12 20:44:36 -0500 | Rating Details | |
2023-08-12 20:44:24 -0500 | Rating Details | |
2023-08-12 20:33:09 -0500 | Rating Details | |
2023-08-12 20:27:35 -0500 | Rating Details | |
2023-08-12 20:18:24 -0500 | Rating Details | |
2023-08-12 20:09:56 -0500 | Rating Details | |
2023-08-12 19:55:07 -0500 | Rating Details | |
2023-08-14 06:38:07 -0500 | Rating Details | |
2023-08-14 04:24:33 -0500 | Rating Details | |
2023-08-14 02:37:02 -0500 | Rating Details | |
2023-08-13 21:32:29 -0500 | Rating Details | |
2023-08-15 12:50:20 -0500 | Rating Details | |
2023-08-14 10:39:00 -0500 | Rating Details | |
2023-08-14 03:59:08 -0500 | Rating Details | |
2023-08-14 02:56:36 -0500 | Rating Details | |
2023-08-13 15:50:33 -0500 | Rating Details | |
2023-08-13 13:06:01 -0500 | Rating Details | |
2023-08-13 09:37:56 -0500 | Rating Details | |
2023-08-13 07:35:11 -0500 | Rating Details | |
2023-08-13 07:25:30 -0500 | Rating Details | |
2023-08-13 07:02:40 -0500 | Rating Details | |
2023-08-13 02:39:23 -0500 | Rating Details | |
2023-08-13 02:33:00 -0500 | Rating Details | |
2023-08-13 01:52:39 -0500 | Rating Details | |
2023-08-12 23:58:46 -0500 | Rating Details | |
2023-08-12 23:18:03 -0500 | Rating Details | |
2023-08-12 21:39:21 -0500 | Rating Details | |
2023-08-12 21:20:40 -0500 | Rating Details | |
2023-08-12 20:13:51 -0500 | Rating Details | |
2023-08-26 22:44:34 -0500 | Rating Details | |
2023-09-03 01:03:13 -0500 | Rating Details | |
2023-12-28 05:54:43 -0600 | Rating Details |